Cyclophosphamide toxicity in Ugandan and American patients with malignant lymphoma.
D000293:Adolescent; D000505:Alopecia / Q000139:chemically induced; D001853:Bone Marrow / Q000187:drug effects; D001856:Bone Marrow Examination; D002051:Burkitt Lymphoma / Q000188:drug therapy*; D002648:Child; D002675:Child, Preschool; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006417:Hematuria / Q000139:chemically induced; D006801:Humans; D007239:Infections; D007275:Injections, Intravenous; D007958:Leukocyte Count; D007962:Leukocytes / Q000187:drug effects; D007970:Leukopenia / Q000139:chemically induced*; D008223:Lymphoma / Q000188:drug therapy*; D008297:Male; D009325:Nausea / Q000139:chemically induced; D013997:Time Factors; D014454:Uganda; D014481:United States; D014839:Vomiting / Q000139:chemically induced
D003520:Cyclophosphamide